— Know what they know.
Not Investment Advice

BRSF OTC

Brain Scientific Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +500.0% 1Y: -99.9% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 50 · $746 mcap · 878010 float · 0.0002% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
-$6M -1.2% ▼
Capital Expenditures
$33K +43.2% ▲
5Y CAGR: +76.3%
Free Cash Flow
-$6M -0.7% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$38K -105.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$1M-$1M-$3M-$9M-$12M
Depreciation & Amort.$656$1K$17K$220K$805K
Stock-Based Comp.$5$31$356K$3K$0
Change in Working Capital$230K$117K$1M-$259K$118K
Other Non-Cash Items-$162K-$60K$4K$6M$5M
Operating Cash Flow-$1M-$855K-$932K-$6M-$6M
— Investing Activities —
Capital Expenditures-$1K-$1K-$30K-$59K-$33K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow-$1K-$1K-$30K-$59K-$33K
— Financing Activities —
Net Debt Issuance$980K$0$761K$7M$6M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$953K$0$0$0
Financing Cash Flow$980K$953K$861K$7M$6M
Net Change in Cash-$134K$98K-$192K$716K-$38K
Cash End of Period$164K$261K$69K$785K$748K
Free Cash Flow-$1M-$856K-$962K-$6M-$6M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms